← Home / AKARI THERAPEUTICS, PLC (AKTX)
Stock Analysis
AKARI THERAPEUTICS, PLC (AKTX)
AKTX
AKTX · Market data
12.00 -7.69%
52W Range Position
20%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-06-18 13:35 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 16.08. Holding above 10.52 keeps the current thesis intact.
⚖️
Fundamentals
Insufficient / Insufficient
Price Structure
Mixed
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
10.52
Break Above
Confirmation improves above resistance.
16.08
🎯
Next Objective
Pattern-derived target if setup continues.
8.43
×
Thesis Break
Scenario weakens below invalidation.
Below 10.52
What's Driving AKTX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 16.08 for confirmation and 10.52 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 10.52 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
Watch Level
27.63
RSI(14)
49.7
How to read this setup
From a roadmap perspective, the setup is boxed by support near 10.52 and resistance around 17.76. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
AKTX · WOI overlay chart
Open Full Workspace
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Insufficient
Profitability
Insufficient
Cash Flow
Mixed
Balance Sheet
Mixed
💵 Revenue
0.00
≈ Insufficient
📈 Net Income
-14.46M
≈ Insufficient
🧮 EPS (Basic)
0.00
≈ Insufficient
AKARI THERAPEUTICS, PLC
Note: This is an algorithmic technical snapshot, not financial advice.